ダウンロード数: 530
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
15_225.pdf | 4.17 MB | Adobe PDF | 見る/開く |
タイトル: | 新尿路造影剤Conray 400について 泌尿器科領域における使用経験 |
その他のタイトル: | Clinical trial of conray 400, new urinary contrast medium, in patients with urinary diseases |
著者: | 鮫島, 博 栗林, 忠央 |
著者名の別形: | SAMESHIMA, Hiroshi KURIBAYASHI, Tadao |
キーワード: | Female Humans Iothalamic Acid/adverse effects Male Urography |
発行日: | Mar-1969 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 15 |
号: | 3 |
開始ページ: | 225 |
終了ページ: | 229 |
抄録: | We applied a new urinary contrast medium, Conray 400, principal ingredient of which is sodium iothalamate, to excretory pyelography, and examined the pyeloureterogram at seven and fifteen minutes after the infusion. The medium had low viscosity and was easy to infuse into vessels. There was no side effect in all the patients with the test-infusion (1 ml) before x-ray exposures. Of 54 patients examined in the study, two had eruption and one had nausea during the examinations. Side effects were observed in only 5.6 %. Vomiting was not observed. No patient complained of vascular pain. The visualizing effect of the medium on pyelography was never inferior to usual contrast media. |
URI: | http://hdl.handle.net/2433/119979 |
PubMed ID: | 5814577 |
出現コレクション: | Vol.15 No.3 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。